University of California San Francisco
Give to UCSFUCSF infectious disease expert Charles Chiu, MD, PhD, has been following the disease since its outbreak and provided the latest updates on what science has revealed about how the coronavirus is transmitted, what happens to someone who’s infected, and why a single diagnostic test may not be enough.
UCSF, which specializes in the care of patients with complex illnesses, including infectious diseases like the novel coronavirus, also treated patients during past epidemics, such as SARS in 2003.
Just weeks since the viral illness was first reported in Wuhan, China, health experts globally are working on containing and treating it.To put the latest news in context, we asked UCSF infectious disease expert Charles Chiu, MD, PhD, about the origins of the Wuhan virus and public health risks going forward.
For 15 years, nobody could figure out what was making a young woman so sick. Then neurologist Michael Wilson, MD, tried a radical new test.
UCSF–led research team has discovered the first conclusive evidence that natural selection may also occur at the level of the epigenome and has done so for tens of millions of years.
Infections that plagued the world for centuries (malaria, HIV/AIDS) are on the verge of eradication. Others threaten to disrupt human lives and economies more than ever before.
A future in which precision medicine benefits everyone is not guaranteed. For that to happen, UCSF experts argue, the health care industry must first tackle today’s health disparities, including differences in disease outcomes and access to care based on race, gender, and socioeconomic status.
The first rigorously controlled study of a 2016 California law that aimed to increase childhood vaccination rates by eliminating nonmedical exemptions has found the law worked as intended.
No one can see the future, but that won’t stop us from trying. We asked UCSF faculty and alumni to score these predictions for likelihood and impact.
From international awards for high-caliber research to groundswell movements for social change, this past year was an eventful one for the UCSF community.
UCSF scientists found that an early-life window of immune tolerance available to a normally harmless bacterial species is firmly closed to another, often pathogenic species — one that is a leading cause of drug-resistant skin infections in the U.S. and occasional source of “flesh-eating” necrosis.
Research team has detected the immunological remnants of a common seasonal virus in spinal fluid from dozens of patients diagnosed with acute flaccid myelitis (AFM). The findings provide the clearest evidence to date that AFM is caused by an enterovirus (EV) that invades and impairs the central nervous system.
In 2017, Valley Fever sent some 14,000 Americans to the doctor’s office, half in California. Most show up with flu-like symptoms and fatigue, but a small number of people develop debilitating infections that spread from the lungs to other parts of the body, including the brain. UCSF researchers are trying to figure how the fungus works and what we can do to stop it.
Malaria, one of the world’s leading killers, could be eradicated as early as 2050, according to a new report.
Pioneering test called metagenomic next-generation sequencing shown to identify infections better than any standard clinical method.
Two-day symposium will bring together scientists from a variety of disciplines to discuss emerging trends in diseases such as Lyme, malaria, dengue, Zika and others that are transmitted by mosquitos, ticks, flies and other arthropod vectors.
The program, supported by philanthropists Herb and Marion Sandler, funds ideas that challenge generally-accepted theories and have potentially transformative effects.
A research team led by scientists at UC San Francisco and the Chan Zuckerberg Biohub has developed a new CRISPR-based diagnostic tool, dubbed FLASH, that can rapidly identify any drug-resistant
Ten finalists competed in the fifth annual Grad Slam to inform and entertain with three-minute talks based on their own research.
TB remains the leading infectious killer of our time, responsible for 1.6 million deaths worldwide in 2017, with drug-resistant forms of TB threatening control efforts in many parts of the world.
The awards, given by the Fred Hutchinson Cancer Research Center, recognize outstanding achievement in graduate studies in the biological sciences.
We invited infectious disease expert and clinician Charles Chiu to answer your questions about the flu.
More than two dozen scientists and researchers participated in the hackathon – a joint project of the Chan Zuckerberg Biohub, the Chan Zuckerberg Initiative and UCSF’s Institute for Global Health Sciences.
From sensory processing disorder to how CRISPR is being explored to bring new treatments to patients, these are the stories that most engaged our readers in 2018.